Test Code LAB124 Testosterone, Total
Useful For
- Evaluation of men with symptoms or signs of possible hypogonadism, such as loss of libido, erectile dysfunction, gynecomastia, osteoporosis, or infertility
- Evaluation of boys with delayed or precocious puberty
- Monitoring testosterone replacement therapy
- Evaluation of women with hirsutism, virilization, and oligoamenorrhea
- Evaluation of women with symptoms or signs of possible testosterone deficiency
Methodology
Electrochemiluminescence Immunoassay (ECLIA)
Performing Laboratory
Bozeman Health Laboratory Services
Specimen Requirements
Specimen Type: Plasma or Serum
Container/Tube: Light green top (Lithium heparin), gold top or red top
Specimen Volume: 2 mL
Specimen Minimum Volume: 1 mL
Specimen Rejection:
- Hemolyzed samples may be rejected.
- Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration.
Specimen Transport Temperature
Ambient/Refrigerated
Specimen Stability
Specimen Type | Temperature | Time |
---|---|---|
Plasma or Serum | Ambient | 5 days |
Refrigerated | 14 days | |
Frozen | 6 months |
Reference Values
Gender | Age | Normal Range |
---|---|---|
Male | ≤9 yrs | 7-29 ng/dL |
10-19 yrs |
123-814 ng/dL |
|
19-40 yrs | 303-852 ng/dL | |
≥40 yrs | ≥300 ng/dL | |
Female | 9-48 ng/dL |
Additional Information
- Phenylbutazone at therapeutic dosage levels showed interference with this assay (testosterone values increased)
- Do not use samples from patients under Nandrolone treatment.
- In isolated cases, elevated testosterone levels can be seen in samples from female patients with end stage renal disease.
- Implausible elevated testosterone values in women should be verified by an extraction method or a validated LC-MS tandem method.
Day(s) Test Set Up
Monday through Friday
Test Classification and CPT Coding
84403